Back to: Research : Division of Intramural Research
Laboratory of Clinical Investigation
Laboratory of Clinical Investigation
(From bottom left to right)
1st row: Ranganath Muniyappa, Jeonga Kim, Michael Quon, Marc Blackman,Howard Baldwin, Patrick Mansky 2nd row: Seraphina Lin, Micaela Iantorno, Yunhua Li, Terrie Kolodziej, Julia Arnold, Dawn Wallerstedt; Tim Sannes 3rd row: Gail Hall, Hui Chen, Monica Montagnani, Sihoon Lee, Nora Gray, Aliya Rainer, Xunxian Liu, 4th row: Sonja Crandon, Chad Reiter, Suzan Khoromi, Bridget Agapito 5th row: Lisa Nackers, Sandra Bloomfield.
Robert B. Nussenblatt, M.D.
Acting Chief, Laboratory of Clinical Investigation
Phone: 301-435-6760
CV for Dr. Nussenblatt (PDF)
The Division of Intramural Research established the Laboratory of Clinical Investigation (LCI) to accomplish the Division's research objectives. The research is centered around the theme of stressors and aging, such as depression, cognitive decline, chronic pain, musculoskeletal frailty, and sleep disorders.
Investigators are studying:
- biologically based therapies, such as DHEA, phytoestrogens, soy, carnitine, and mistletoe
- alternative medical systems, such as acupuncture
- mind-body medicine, such as placebo effect, meditation, and spirituality.
The LCI will ultimately be composed of five sections:
- Clinical Immunology
- Clinical Pharmacology
- Endocrine
- Musculoskeletal Biology and Cancer
- Neurobiology
Note: An Oncology Program is currently located within the Office of the Scientific Director.
Note: The PDF file requires a viewer such as Adobe Reader, which you can download free of charge from the Adobe Web site.
